Journal article
Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumors
C Devaud, JA Westwood, MWL Teng, LB John, CSM Yong, CPM Duong, MJ Smyth, PK Darcy, MH Kershaw
Oncoimmunology | TAYLOR & FRANCIS INC | Published : 2014
Abstract
In many cancers, regulatory T cells (Treg) play a crucial role in suppressing the effector immune response thereby permitting tumor development. Indeed, in mouse models, their depletion can promote the regression of tumors of various origins, including renal cell carcinoma when located subcutaneous (SC). In the present study, we aimed to assess the importance of Treg immunosuppression in the physiologic context of metastatic renal carcinoma (Renca) disease. To that purpose we inoculated renal tumors orthotopically, intra-kidney (IK), in mice. Treg depletions were performed using anti-CD4 antibody in wild type mice or diphtheria toxin (DT) in Foxp3DTR transgenic mice. Our main observation was..
View full abstractGrants
Funding Acknowledgements
This work was supported by funding from the Cancer Council of Victoria and the National Health and Medical Research Council of Australia (NHMRC). MHK and PKD were supported by Senior Research Fellowships from the NHMRC. MJS and MWLT were supported by a NHMRC Australia Fellowship and a Career Development Award respectively.